Massimo Pinzani

Professor Pinzani co-founded Engitix in 2016 and now serves on the Board of Directors.

With more than 30 years of experience in the field of hepatology and liver diseases as a Professor of Medicine and clinical and translational hepatologist, Professor Pinzani is an internationally renowned liver disease specialist. Since 2012, he has been Director of the UCL Institute for Liver and Digestive Health (ILDH) and the Sheila Sherlock Chair of Hepatology at UCL.

Professor Pinzani is a pioneer in research dedicated to cellular and molecular mechanisms of liver fibrosis and a key contributor to relative diagnostic and therapeutic approaches in the evaluation of disease progression. His research has continuously been funded by national and international organisations since 1994.

He serves as Chairman of the European Association for the Study of the Liver (EASL) Consortium for Regenerative Hepatology, following his roles as Educational Councillor and member of the Governing Board of EASL from 2015 to 2019.

Professor Pinzani has authored 200 original research publications,and served as Editor-in-Chief and Associate Editor, for several prestigious international peer-reviewed journals.